Data complete?
Evaluation appropriate?
Number of findings that may indicate nephrogenic systemic fibrosis
Is the patient at risk for GBCA-related NSF?
Should a skin biopsy be performed to identify fibrosis?
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To evaluate a patient for nephrogenic systemic fibrosis (NSF) following use of a gadolinium-based contrast agent (GBCA) during an MRI.
Specialty: Hematology Oncology, Pharmacology, clinical
Objective: response to therapy, adverse effects, complication detection
ICD-10: N00-N99,